Skip to main content
. 2017 Sep 12;6(8):595–600. doi: 10.1530/EC-17-0130

Table 2.

Efficacy of the two treatments in controlling blood pressure among preeclampsia patients.

Primary endpoints NIFE + RESV (n = 174) NIFE + placebo (n = 175) P value
Time to control blood pressure (min) 35.6 ± 18.7 51.1 ± 22.4 0.01
Time before a new hypertensive crisis (h) 8.0 ± 2.1 5.5 ± 1.8 0.02

NIFE, nifedipine; RESV, resveratrol.